Gotowe bibliografie tematyczne / Aminoglycoside antibiotics / Książki

Książki na temat „Aminoglycoside antibiotics”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Aminoglycoside antibiotics.
Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 20 lutego 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 18 najlepszych książek naukowych na temat „Aminoglycoside antibiotics”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

Arya, D. P. Aminoglycoside antibiotics: From chemical biology to drug discovery. Hoboken, N.J: Wiley-Interscience, 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Lazenby, Charles Mark. The effect of aminoglycoside antibiotics on erythrocyte membrane potassium ion transport. Birmingham: Aston University. Department of Pharmaceutical Sciences, 1989.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Umezawa, Hamao, i Irving R. Hooper. Aminoglycoside Antibiotics. Brand: Springer, 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Arya, Dev P., red. Aminoglycoside Antibiotics. Wiley, 2007. http://dx.doi.org/10.1002/9780470149676.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Koeda, T., Y. Ito, Hamao Umezawa i Irving R. Hooper. Aminoglycoside Antibiotics. Springer London, Limited, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Barnes, William G., i Glenn R. Hodges. Aminoglycoside Antibiotics a Guide to Therapy. Taylor & Francis Group, 2019.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Barnes, William G., i Glenn R. Hodges. Aminoglycoside Antibiotics a Guide to Therapy. Taylor & Francis Group, 2019.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Barnes, William G., i Glenn R. Hodges. Aminoglycoside Antibiotics a Guide to Therapy. Taylor & Francis Group, 2019.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Barnes, William G., i Glenn R. Hodges. Aminoglycoside Antibiotics: A Guide to Therapy. Taylor & Francis Group, 2019.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Barnes, William G., i Glenn R. Hodges. Aminoglycoside Antibiotics a Guide to Therapy. Taylor & Francis Group, 2019.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
11

Barnes, William G., i Glenn R. Hodges, red. The Aminoglycoside Antibiotics: A Guide To Therapy. CRC Press, 2019. http://dx.doi.org/10.1201/9780429280184.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

Arya, Dev P. Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery. Wiley & Sons, Incorporated, John, 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Schroeder, Renee, i Mary G. Wallis. RNA-Binding Antibiotics (American Rustic). Landes Bioscience, 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Herald, Patricia Ann. RELATIONSHIP BETWEEN HYDRATION STATUS AND RENAL FUNCTION IN PATIENTS RECEIVING AMINOGLYCOSIDE ANTIBIOTICS. 1993.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Rusnak, Donald E. Establishment of a pharmacokinetic monitoring service for aminoglycoside antibiotics at National Defence Medical Centre. 1986.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Arya, Dev P. Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery (Wiley Series in Drug Discovery and Development). Wiley-Interscience, 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

Gilchrist, Francis J., i Alex Horsley. Management of respiratory exacerbations. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780198702948.003.0005.

Pełny tekst źródła
Streszczenie:
Cystic fibrosis lung disease is characterized by chronic infection, inflammation and a progressive loss of lung function. Patients are also affected by recurrent episodes of increased respiratory symptoms, called exacerbations which have a detrimental effect on quality of life, the rate of lung function decline, and mortality. Early diagnosis and treatment is vital. Diagnosis relies on a combination of symptoms, examination findings, the results of laboratory tests, and lung function. Antibiotics are the mainstay of treatment but airway clearance, nutrition, and glucose homeostasis must also be optimized. Mild exacerbations are usually treated with oral antibiotics and more severe exacerbations with intravenous antibiotics. The choice of antibiotic is guided by the patient’s chronic pulmonary infections, the in-vitro antibiotic sensitivities, known antibiotic allergies, and the previous response to treatment. In patients with chronic Pseudomonas aeruginosa infection, antibiotic monotherapy is thought to increase the risk of resistance and treatment with 2 antibiotics is therefore suggested (usually a β‎-lactam and an aminoglycoside). Although there is a lack of evidence on the duration of treatment, most patients receive around 14 days. This can be altered according to the time taken for symptoms and lung function to return to pre-exacerbation levels. If patients are carefully selected and receive appropriate monitoring, home intravenous antibiotics can be as effective as in-patient treatment. They are also associated with decreased disruption to patients / family life, decreased risk of cross infection and decreased costs.
Style APA, Harvard, Vancouver, ISO itp.
18

Goffin, Eric, Laura Labriola i Michel Jadoul. Bacterial and fungal infections in patients on peritoneal dialysis. Redaktor Jonathan Himmelfarb. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0270.

Pełny tekst źródła
Streszczenie:
Infections specifically related to peritoneal dialysis include peritonitis on the one hand, and exit-site and tunnel infections on the other hand.The diagnosis of peritonitis rests on the classical triad of cloudy dialysate, abdominal pain, and presence of < 100 white-cells (including < 50 % polymorphonuclear cells) within the dialysate effluent. Because peritonitis is associated with high mortality and morbidity rates, empiric antibiotics should be initiated without delay, covering both Gram-positive and Gram-negative organisms. Most regimens include vancomycin or a first-generation cephalosporin for the former, and a third-generation cephalosporin or an aminoglycoside for the latter. Antibiotics are usually administered via the intraperitoneal route. Prophylaxis with an anti-fungal agent has to be considered in diabetic patients and in those who just received prolonged antibiotic administration. Cure is obtained in up to 80 % of the cases ; treatment failure however may occur with refractory or relapsing peritonitis episodes. This is especially common in fungal or fecal associated peritonitis, and will require catheter withdrawal. The incidence of peritonitis has dramatically decreased in recent years with the advent of new connectology systems, and both adequate preventive measures and improved patients’ education. Still it is not clearly documented that new biocompatible dialysate fluids have a favorable effect on peritonitis incidence.Exit-site and tunnel infections are defined by the presence of a purulent discharge around the catheter and by erythema, oedema and tenderness of the subcutaneous pathway of the catheter, respectively. Antibiotics are recommended in case of documented infection. Cuff shaving may sometimes be required, as well as catheter removal in case of unfavourable evolution.
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany bibliografiami na temat „Aminoglycoside antibiotics” dla innych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii